Overall, our findings suggest that repeated infusions of ketamine may produce a positive and longer-term effect on BMD, and leptin and OC may be the potential biomarkers of antidepressant response to ketamine in female and male patients with depression, respectively. The gene discussed is LEP; the disease is depressive symptom measurement.